Addus HomeCare (ADUS)
(Delayed Data from NSDQ)
$128.72 USD
-4.31 (-3.24%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $128.78 +0.06 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$128.72 USD
-4.31 (-3.24%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $128.78 +0.06 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Zacks News
What's in Store for Thermo Fisher (TMO) in Q3 Earnings?
by Zacks Equity Research
Developments in business segments are likely to have aided Thermo Fisher (TMO) in the third quarter.
Can Sequencing Products Drive Illumina's (ILMN) Q3 Earnings?
by Zacks Equity Research
Illumina (ILMN) is taking a cautious approach after a disappointing second quarter.
Why the Earnings Surprise Streak Could Continue for Addus HomeCare (ADUS)
by Zacks Equity Research
Addus HomeCare (ADUS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Reasons Why Addus HomeCare (ADUS) Is a Great Growth Stock
by Zacks Equity Research
Addus HomeCare (ADUS) could produce exceptional returns because of its solid growth attributes.
DGX vs. ADUS: Which Stock Is the Better Value Option?
by Zacks Equity Research
DGX vs. ADUS: Which Stock Is the Better Value Option?
Addus HomeCare (ADUS) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Addus HomeCare (ADUS) delivered earnings and revenue surprises of 3.70% and 2.07%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Addus HomeCare (ADUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Ranked Momentum Stocks to Buy for July 16th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 16th.
Top Ranked Momentum Stocks to Buy for July 15th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 15th.
Addus HomeCare (ADUS) Is Up 0.43% in One Week: What You Should Know
by Zacks Equity Research
Does Addus HomeCare (ADUS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Top Ranked Momentum Stocks to Buy for July 2nd
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 2nd.
Addus HomeCare (ADUS) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Addus HomeCare (ADUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Top Ranked Momentum Stocks to Buy for June 17th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, June 17th.
LHCG or ADUS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
LHCG vs. ADUS: Which Stock Is the Better Value Option?
Addus HomeCare (ADUS) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Addus HomeCare (ADUS) delivered earnings and revenue surprises of 13.04% and -0.08%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Addus HomeCare (ADUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ADUS or USPH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ADUS vs. USPH: Which Stock Is the Better Value Option?
Quest Diagnostics (DGX) Jumps: Stock Rises 9.3%
by Zacks Equity Research
Quest Diagnostics (DGX) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Here's Why You Should Bet on Cooper Companies (COO) Stock Now
by Zacks Equity Research
Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across its segments and prudent acquisitions.
Here's Why You Should Hold on to DaVita (DVA) Stock Now
by Zacks Equity Research
DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, rising expenses remain a dampener.
ADUS vs. USPH: Which Stock Is the Better Value Option?
by Zacks Equity Research
ADUS vs. USPH: Which Stock Is the Better Value Option?
Addus HomeCare (ADUS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Addus HomeCare (ADUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LHCG vs. ADUS: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
LHCG vs. ADUS: Which Stock Is the Better Value Option?
ADUS vs. AMED: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ADUS vs. AMED: Which Stock Is the Better Value Option?
Weekly Jobless Claims Lowest Since November 1969: 5 Picks
by Nalak Das
The U.S. labor market is a picture of health at the moment fueled by strong job additions and record-low unemployment.